Armed Forces Capital Hospital
Seongnam-si, Gyeonggi-do, 463-040, South Korea
NCT Number: NCT01038830
The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.
Looking for future studies?
Notify MeAll sexes
Observational
Seongnam-si, Gyeonggi-do, 463-040, South Korea
Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeArmed Forces Capital Hospital, Republic of Korea
Other Gov
The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04121026
Actinomycetales Infections, Bacterial Infections
Abidjan, Côte d’Ivoire
View Trial DetailsNCT04618198
Actinomycetales Infections, Bacterial Infections
Sanya Juu, Tanzania
View Trial DetailsNCT04926922
Actinomycetales Infections, Bacterial Infections
Bethesda, Maryland, United States
View Trial DetailsNCT02563327
Actinomycetales Infections, Bacterial Infections
Kampala, Uganda
View Trial Details